| Real-time ultrasound-guided catheterisation of the internal jugular vein: a prospective comparison with the landmark technique in critical care patients D Karakitsos, N Labropoulos, E De Groot, AP Patrianakos, G Kouraklis, ... Critical Care 10, 1-8, 2006 | 861 | 2006 |
| Fosfomycin ME Falagas, EK Vouloumanou, G Samonis, KZ Vardakas Clinical microbiology reviews 29 (2), 321-347, 2016 | 646 | 2016 |
| FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal … J Souglakos, N Androulakis, K Syrigos, A Polyzos, N Ziras, ... British journal of cancer 94 (6), 798-805, 2006 | 520 | 2006 |
| Fungal infections complicating tumor necrosis factor α blockade therapy S Tsiodras, G Samonis, DT Boumpas, DP Kontoyiannis Mayo Clinic Proceedings 83 (2), 181-194, 2008 | 383 | 2008 |
| Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria ME Falagas, IA Bliziotis, SK Kasiakou, G Samonis, P Athanassopoulou, ... BMC infectious diseases 5, 1-7, 2005 | 351 | 2005 |
| Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: retrospective analysis of 245 episodes I Chatzinikolaou, D Abi-Said, GP Bodey, KVI Rolston, JJ Tarrand, ... Archives of internal medicine 160 (4), 501-509, 2000 | 342 | 2000 |
| Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case–control study ME Falagas, PI Rafailidis, D Kofteridis, S Virtzili, FC Chelvatzoglou, ... Journal of antimicrobial chemotherapy 60 (5), 1124-1130, 2007 | 322 | 2007 |
| Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials KZ Vardakas, GL Voulgaris, A Maliaros, G Samonis, ME Falagas The Lancet infectious diseases 18 (1), 108-120, 2018 | 305 | 2018 |
| Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence KZ Vardakas, KA Polyzos, K Patouni, PI Rafailidis, G Samonis, ... International journal of antimicrobial agents 40 (1), 1-8, 2012 | 304 | 2012 |
| Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis SK Kasiakou, A Michalopoulos, ES Soteriades, G Samonis, GJ Sermaides, ... Antimicrobial agents and chemotherapy 49 (8), 3136-3146, 2005 | 269 | 2005 |
| A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic … GP Stathopoulos, K Syrigos, G Aravantinos, A Polyzos, P Papakotoulas, ... British journal of cancer 95 (5), 587-592, 2006 | 262 | 2006 |
| Effect of aminoglycoside and β-lactam combination therapy versus β-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials IA Bliziotis, G Samonis, KZ Vardakas, S Chrysanthopoulou, ME Falagas Clinical infectious diseases 41 (2), 149-158, 2005 | 256 | 2005 |
| Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study DP Kofteridis, C Alexopoulou, A Valachis, S Maraki, D Dimopoulou, ... Clinical infectious diseases 51 (11), 1238-1244, 2010 | 250 | 2010 |
| Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III randomized trial V Georgoulias, A Ardavanis, X Tsiafaki, A Agelidou, P Mixalopoulou, ... Journal of clinical oncology 23 (13), 2937-2945, 2005 | 242 | 2005 |
| Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans G Samonis, A Gikas, EJ Anaissie, G Vrenzos, S Maraki, Y Tselentis, ... Antimicrobial agents and chemotherapy 37 (1), 51-53, 1993 | 221 | 1993 |
| Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin ME Falagas, S Maraki, DE Karageorgopoulos, AC Kastoris, ... International journal of antimicrobial agents 35 (3), 240-243, 2010 | 216 | 2010 |
| Aspergillus cell wall melanin blocks LC3-associated phagocytosis to promote pathogenicity T Akoumianaki, I Kyrmizi, I Valsecchi, MS Gresnigt, G Samonis, E Drakos, ... Cell host & microbe 19 (1), 79-90, 2016 | 213 | 2016 |
| Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections N Roussos, DE Karageorgopoulos, G Samonis, ME Falagas International journal of antimicrobial agents 34 (6), 506-515, 2009 | 213 | 2009 |
| Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study DK Matthaiou, A Michalopoulos, PI Rafailidis, DE Karageorgopoulos, ... Critical care medicine 36 (3), 807-811, 2008 | 213 | 2008 |
| Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa … G Samonis, S Maraki, DE Karageorgopoulos, EK Vouloumanou, ... European journal of clinical microbiology & infectious diseases 31, 695-701, 2012 | 211 | 2012 |
